Business Context and Reporting Period
Medirom Healthcare Technologies Inc., a Japanese foreign private issuer, furnished this Form 6-K for May 2022. The filing announces the issuance of a press release containing preliminary unaudited consolidated financial results for the year ended December 31, 2021.
The filing was signed on May 6, 2022, by Fumitoshi Fujiwara, Chief Financial Officer. The press release was furnished as Exhibit 99.1 and is not deemed “filed” for purposes of Section 18 of the Securities Exchange Act.
Financial Metrics
The Form 6-K text does not provide revenue, profit or loss, cash flow, margins, debt, liquidity, or other financial figures. It states that these matters are addressed in the attached preliminary unaudited financial-results press release, but that exhibit is not included in the provided text.
Material Changes Versus the Prior Comparable Period
The filing text does not provide comparative financial information or describe material year-over-year changes.
Guidance, Outlook, Risks, and Unusual Items
No guidance, outlook, management commentary, risks, contingencies, or unusual items are described in the provided Form 6-K text. The reported results are expressly preliminary and unaudited.
Important Facts to Verify
- Obtain and review Exhibit 99.1 for the actual 2021 consolidated financial results and comparative figures.
- Verify whether the preliminary results were subsequently revised in audited annual reporting or later SEC filings.
- Review any management commentary, outlook, liquidity disclosures, debt information, and risk factors contained in the press release or subsequent Form 20-F.
- Confirm the scope of consolidation and accounting basis used for the preliminary results.